• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors.

作者信息

Yamada S, Sugimoto N, Uchida S, Deguchi Y, Kimura R

机构信息

Department of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Japan.

出版信息

J Cardiovasc Pharmacol. 1994 Mar;23(3):466-72.

PMID:7515992
Abstract

We characterized the occupancy of dihydropyridine (DHP) calcium antagonist receptors by amlodipine in spontaneously hypertensive rats (SHR) in relation to its pharmacokinetics. Oral administration of amlodipine (10 mg/kg) in SHR produced a significant (20-70%) decrease in the number of specific (+)[3H]PN 200-110 binding sites in cardiac tissues 0.5-18 h later, and the effect was greatest 3 h later. In these rats, there was little change in cerebral cortical (+)[3H]PN 200-110 binding. Occupancy of cardiac calcium antagonist receptors after oral administration of amlodipine correlated well with its plasma concentration. In vitro blockade of cardiac (+)[3H]PN 200-110 binding sites induced by amlodipine also persisted after the tissues were washed by centrifugation and suspension, whereas that induced by nifedipine was reversible under these conditions. Thus, our results suggest that the gradual onset and long-lasting pharmacologic effect of amlodipine are due to its slow binding kinetics (association and dissociation) of cardiovascular receptor sites in addition to its slow pharmacokinetics.

摘要

相似文献

1
Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors.
J Cardiovasc Pharmacol. 1994 Mar;23(3):466-72.
2
A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats.美哌地尔在体内对心血管钙拮抗剂受体的持续占据及其与自发性高血压大鼠药效学效应的关系。
J Pharmacol Exp Ther. 1992 Aug;262(2):589-94.
3
In vivo receptor binding of benidipine and amlodipine in mesenteric arteries and other tissues of spontaneously hypertensive rats.贝尼地平与氨氯地平在自发性高血压大鼠肠系膜动脉及其他组织中的体内受体结合情况。
Life Sci. 2002 Mar 15;70(17):1999-2011. doi: 10.1016/s0024-3205(01)01541-7.
4
In vivo receptor occupancy and plasma concentration of pranidipine, a potent and long-acting dihydropyridine calcium antagonist.强效长效二氢吡啶类钙拮抗剂普拉地平的体内受体占有率和血浆浓度
Pharmacology. 1999 Oct;59(4):171-82. doi: 10.1159/000028318.
5
Vascular and myocardial effects of amlodipine: an overview.氨氯地平对血管和心肌的作用:综述
Postgrad Med J. 1991;67 Suppl 5:S41-3.
6
Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.新型1,4 - 二氢吡啶类钙拮抗剂乐卡地平的体外药理学研究
Arzneimittelforschung. 1996 Jan;46(1):15-24.
7
Correlation between the plasma concentration of mepirodipine and its occupancy of Ca2+ antagonist receptors in rats.大鼠体内甲哌地平血浆浓度与其对钙离子拮抗剂受体占有率的相关性。
Pharm Res. 1993 Sep;10(9):1346-9. doi: 10.1023/a:1018982116273.
8
Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes.带正电荷的1,4 - 二氢吡啶类钙通道拮抗剂氨氯地平与该类不带电荷药物在心肌膜中的定位和结合比较。
Mol Pharmacol. 1989 Oct;36(4):634-40.
9
Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine.衰老大脑中钙拮抗剂受体和钙含量的改变以及尼莫地平和尼卡地平的衰减作用
J Pharmacol Exp Ther. 1996 May;277(2):721-7.
10
Amlodipine: a once daily calcium antagonist.氨氯地平:一种每日服用一次的钙拮抗剂。
J Hum Hypertens. 1991 Aug;5 Suppl 1:49-54.

引用本文的文献

1
Receptor occupancy in myocardium, adrenal cortex, and brain by TH-142177, a novel AT1 receptor antagonist in rats, in relation to its plasma concentration and hypotensive effect.新型AT1受体拮抗剂TH-142177在大鼠心肌、肾上腺皮质和脑中的受体占有率及其与血浆浓度和降压作用的关系。
Pharm Res. 1998 Jun;15(6):911-7. doi: 10.1023/a:1011932800729.